Antibe engages global CMO to support planned pain drug partnership
Antibe tasks global CMO with providing a reliable supply of pain drug, ATB-346.
Archives for December 16, 2019
Catalent to formulate CBD multiple sclerosis treatment with Zydis
Catalent enters partnership with Ethicann on Zydis technology to formulate CBD and THC combination treatment for muscular spasticity.
Amneal invests $340m in generics distributor
Amneal announces acquisition of 65.1% majority interest of generics distributing company, AvKARE, boosting its presence in the generics and federal healthcare market.
Agilent sets sights on filling new nucleic acid plant by 2021
Agilent looks to fill new nucleic acid capacity by end of 2020, eyes further expansions.